Guardant Health
GH
$25.36
Share price
-3.35%
Change (1 day)
-14.09%
Change (1 year)
Categories
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.
Earnings for Guardant Health (GH)
Earnings in 2023 (TTM): -$0.48 B
According to Guardant Health 's latest financial reports the company's current earnings (TTM) are -$0.48 B. In 2022 the company made an earning of -$0.66 B a decrease over its 2021 earnings that were of -$0.39 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Guardant Health from 2018 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.48 B | -26.73% |
| 2022 | -$0.66 B | 69.96% |
| 2021 | -$0.39 B | 56.35% |
| 2020 | -$0.25 B | 252.69% |
| 2019 | -$69.73 M | -17.22% |
| 2018 | -$84.23 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Neogen NEOG | -$0.26 M | -99.95% | 🇺🇸 USA |
 Natera NTRA | -$0.44 B | -9.24% | 🇺🇸 USA |